Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis.
Eur Respir J
; 41(6): 1393-400, 2013 Jun.
Article
in En
| MEDLINE
| ID: mdl-23018916
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxazoles
/
Tuberculosis, Multidrug-Resistant
/
Extensively Drug-Resistant Tuberculosis
/
Nitroimidazoles
/
Antitubercular Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur Respir J
Year:
2013
Document type:
Article
Affiliation country:
Latvia